发明名称 Tetrahydroquinoline compounds
摘要 Tetrahydroquinoline compounds of general formula (I) or pharmacologically acceptable salts thereof, which have a specific and strong binding affinity for AR, exhibit AR agonism or antagonism, have therapeutic effects on AR-mediated diseases, particularly by not acting excessively on the prostate as AR agonists, but by showing potent action on skeletal muscle tissue and bone tissue; and pharmaceutical compositions comprising the compounds or the salts as active ingredients:
申请公布号 US6777427(B2) 申请公布日期 2004.08.17
申请号 US20030380589 申请日期 2003.03.13
申请人 KAKEN PHARMACEUTICAL CO., LTD. 发明人 MIYAKAWA MOTONORI;AMANO SEIJI;KAMEI MISA;HANADA KEIGO;FURUYA KAZUYUKI;YAMAMOTO NORIKO
分类号 A61K31/47;A61P5/26;A61P5/28;A61P7/06;A61P13/08;A61P15/00;A61P15/08;A61P15/10;A61P17/00;A61P19/00;A61P19/10;A61P21/00;A61P35/00;C07D215/22;C07D215/233;C07D215/36;C07D215/42;C07D215/44;C07D215/48;C07D401/04;C07F7/18;(IPC1-7):A61K31/47;C07D215/16;C07D215/14;C07D215/00;C07D215/18 主分类号 A61K31/47
代理机构 代理人
主权项
地址